Dr. Emmanuel A. Quaidoo, MD

Dr. Quaidoo practices at Alexander Park Campus - Diabetes and Endocrinology in Rochester, New York.

Dr. Quaidoo's NPI, 1134197387, was assigned on March 14, 2006. Dr. Quaidoo holds New York license 193211.

Dr. Quaidoo's primary practice is Alexander Park Campus - Diabetes and Endocrinology, at 224 Alexander St, Rochester, NY 14607 in Monroe County. The practice phone is (585) 922-8400.

Dr. Quaidoo's primary practice is Alexander Park Campus - Diabetes and Endocrinology in Rochester, New York. Dr. Quaidoo is also affiliated with Strong Memorial Hospital. The medical group on file is Rochester General Hospital. Dmand AI also links Dr. Quaidoo to 2 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Quaidoo practices, 6 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Quaidoo's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Quaidoo is licensed in New York.

CMS data shows 196 Medicare services from Dr. Quaidoo across 3 procedure codes in 2024, all of them office visits, for 138 Medicare patients. Medicare paid $13,379 for them. Every service was in an office.

CMS counts 138 Medicare patients who saw Dr. Quaidoo in 2024. The largest group is 65 to 74, with 59 patients. 75% of them have arthritis, and 75% have high blood pressure. 26% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Quaidoo's median patient age at 65, with 76% women.

In 2024, Dr. Quaidoo wrote 1,900 Medicare Part D claims for 510 patients. 87% of them were for generic drugs. CMS names the drug for 1,580 of them, across 29 drugs with 11 or more claims each, at $486,714 in total drug cost. In 2023, CMS named 1,463 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Quaidoo for performance year 2024, reported through an alternative payment model (APM). Dr. Quaidoo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Quaidoo as offering telehealth.

Dmand AI links 1 paper to Dr. Quaidoo in 2021. Dr. Quaidoo's most frequent co-authors are Mindy Duong and Emmanuel Anthony Quaidoo.

CMS Open Payments shows 303 general payments to Dr. Quaidoo from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 83% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,123.